Solventum Corp
Close on Oct 19, 2026
- Market cap
- $14.74B
- P/E (TTM)
- 10.4
- Dividend yield
- –
Earnings
Next report expected Nov 5, 2026, during market hours (estimated from past report dates)
| Quarter | Reported | Time | Revenue | EPS (GAAP) | EPS (adjusted) |
|---|---|---|---|---|---|
| Q2 FY2026 Ended Jun 30, 2026 | Aug 5, 2026 | During market hours | $2.20B | $0.53 | $2.55 |
| Q1 FY2026 Ended Mar 31, 2026 | May 5, 2026 | During market hours | – | – | – |
| Q4 FY2025 Ended Dec 31, 2025 | Feb 26, 2026 | During market hours | $2.00B | $0.36 | $1.57 |
| Q3 FY2025 Ended Sep 30, 2025 | Nov 6, 2025 | During market hours | $2.10B | $7.22 | $1.50 |
| Q2 FY2025 Ended Jun 30, 2025 | Aug 7, 2025 | During market hours | – | – | – |
| Q1 FY2025 Ended Mar 31, 2025 | May 8, 2025 | During market hours | – | – | – |
| Q4 FY2024 Ended Dec 31, 2024 | Feb 27, 2025 | During market hours | – | – | – |
| Q3 FY2024 Ended Sep 30, 2024 | Nov 7, 2024 | During market hours | – | – | – |
| Q2 FY2024 Ended Jun 30, 2024 | Aug 8, 2024 | During market hours | – | – | – |
| Q1 FY2024 Ended Mar 31, 2024 | May 9, 2024 | Before market open | – | – | – |
Company guidance
Outlook given with results on Aug 5, 2026, compared with the previous outlook
| Measure | Period | Guidance | vs. prior |
|---|---|---|---|
| adjusted EPSnon-GAAP | full year 2026 | $7.10 to $7.20 | Raised |
| free cash flownon-GAAP | full year 2026 | $200.00M to $300.00M | Raised |
| organic sales growthnon-GAAP | full year 2026 | 2.5% to 3% growth | Raised |
Figures and the sentence they come from are taken from the company's earnings release. Hover a measure to read the source sentence.
Press releases
Announcements Solventum filed with the SEC
Solventum Reports Second Quarter 2026 Financial Results
Results of operations · EX-99.1 to Form 8-K
Solventum Announces Intent to Separate its Health Information Systems Business
Regulation FD disclosure · Other events · EX-99.1 to Form 8-K
N THE COURT OF CHANCERY OF THE STATE OF DELAWARE
Other events · EX-99.1 to Form 8-K
Solventum Reports First Quarter 2026 Financial Results
Results of operations · EX-99.1 to Form 8-K
Solventum Reports Fourth Quarter 2025 Financial Results and Introduces 2026 Full-Year Guidance
Results of operations · EX-99.1 to Form 8-K
Reflections on a year of growth and transformation
Regulation FD disclosure · EX-99.1 to Form 8-K
Solventum Reports Third Quarter 2025 Financial Results
Results of operations · EX-99.1 to Form 8-K
Solventum Announces Early Tender Results and Upsizing of its Note Tender Offers
Other events · EX-99.1 to Form 8-K
Solventum Announces Pricing of its Upsized $2 Billion Note Tender Offers
Other events · EX-99.2 to Form 8-K
Solventum Completes Sale of its Purification & Filtration Business
Acquisition or disposition completed · Regulation FD disclosure · EX-99.1 to Form 8-K
Solventum Announces $1.75 Billion Note Tender Offers
Other events · EX-99.1 to Form 8-K
Solventum Announces Pricing of Secondary Offering of Common Stock
Other events · EX-99.1 to Form 8-K
Unaudited Pro Forma Condensed Consolidated Financial Statements
Regulation FD disclosure · EX-99.1 to Form 8-K
Solventum Reports Second Quarter 2025 Financial Results
Results of operations · EX-99.1 to Form 8-K
Solventum Reports First Quarter 2025 Financial Results
Results of operations · EX-99.1 to Form 8-K
Solventum Reports Fourth Quarter 2024 Financial Results and Introduces 2025 Full-Year Guidance
Results of operations · EX-99.1 to Form 8-K
Solventum Reports Third Quarter 2024 Financial Results and Raises Full-Year Guidance
Results of operations · EX-99.1 to Form 8-K
Solventum Reports Second Quarter 2024 Financial Results and Raises Full-Year Guidance
Results of operations · EX-99.1 to Form 8-K
Solventum Reports First Quarter 2024 Financial Results and Capital Allocation Update
Results of operations · EX-99.1 to Form 8-K
Solventum Begins Trading on the New York Stock Exchange
Material agreement · Executive or director change · Charter or bylaw amendment · Other events · EX-99.2 to Form 8-K
For U.S. federal income tax purposes, the distribution is intended to be generally tax-free to 3M shareholders.
Regulation FD disclosure · EX-99.1 to Form 8-K